Mast cell numbers in airway smooth muscle and PC 20 AMP in asthma and COPD
|
|
- Lucinda Newman
- 6 years ago
- Views:
Transcription
1 Respiratory Medicine (2007) 101, Mast cell numbers in airway smooth muscle and PC 20 AMP in asthma and COPD J.J.W. Liesker a, N.H.T. ten Hacken a,, S.R. Rutgers a, M. Zeinstra-Smith b, D.S. Postma a, W. Timens b a Department of Pulmonology, University Medical Center Groningen, University of Groningen, the Netherlands b Department of Pathology, University Medical Center Groningen, University of Groningen, the Netherlands Received 12 April 2006; accepted 2 October 2006 Available online 13 November 2006 KEYWORDS Mast cell; Adenosine; Asthma; COPD; Bronchial hyperresponsiveness; Airway smooth muscle Summary Introduction: Most patients with asthma and many patients with COPD show bronchial hyperresponsiveness to adenosine (BHR AMP ). BHR AMP may be caused by release of mast cell histamine, which induces smooth muscle contraction. Aim of the study: To evaluate whether mast cell numbers in airway smooth muscle are increased in patients with asthma and COPD compared to their age-matched controls, and whether mast cell numbers are correlated with BHR AMP. Patients: Twenty-two non-smoking subjects with asthma (age 31 yr, FEV 1 : 89% pred, PC 20 AMP: 2.7 mg/ml), 18 ex-smoking subjects with COPD (age 62 yr, FEV 1 : 58% pred, PC 20 AMP: 52.4 mg/ml). Methods: Snap-frozen bronchial biopsies were immunostained with anti-mast cell tryptase and anti-desmin antibodies. Mast cell number was expressed as the number of tryptase positive cells per area of smooth muscle. Results: There were no significant differences in mast cell number between patients with asthma, COPD, and their respective age-matched healthy controls. Furthermore, there was no significant correlation between mast cell number and FEV 1 or PC 20 AMP in any of the groups. Surprisingly, the mast cell number was negatively correlated with reversibility to salbutamol in COPD patients (rho 0.47, Po0:05). Conclusion: Mast cell numbers in central airway smooth muscle apparently do not contribute importantly to bronchial hyperresponsiveness to adenosine. & 2006 Elsevier Ltd. All rights reserved. Introduction Corresponding author. Tel.: ; fax: address: n.h.t.ten.hacken@int.umcg.nl (N.H.T. ten Hacken). Most patients with asthma and many smoking patients with COPD show increased bronchial hyperresponsiveness to adenosine (BHR AMP ). 1,2 The underlying mechanism of this BHR AMP is not completely understood, partially because /$ - see front matter & 2006 Elsevier Ltd. All rights reserved. doi: /j.rmed
2 Mast cells in airway smooth muscle 883 there are no selective adenosine receptor antagonists available in humans so far. Probably, adenosine acts indirectly through activation of specific (A2) receptors on intermediate inflammatory cells such as mast cells and on afferent nerve endings. 3 A role of mast cells in the responsiveness to adenosine is supported by the observation that plasma histamine increases in atopic non-asthmatics after a challenge with AMP, 4 next to histamine, prostaglandin D2 and tryptase increases in bronchoalveolar lavage fluid. 5 Because BHR AMP may well depend on the number and activation state of bronchial mast cells, this test might be a useful marker of allergic airway inflammation in clinical practice. 6 Indeed, atopic subjects respond relatively more to inhaled adenosine than to methacholine as compared to non-atopic controls. 4 Also, the early asthmatic reaction after house dust mite is better reflected by an increase in hyperresponsiveness to AMP than to methacholine. 7,8 Nonatopic patients with COPD who currently smoke show also more severe hyperresponsiveness to AMP than ex-smokers. 9 Because the number of mast cells is larger in the peripheral 10 as well as the central airways 11 of smokers than of non-smokers, mast cells may also play a role in the increased hyperresponsiveness to AMP in smoking-related airway diseases. Based on the above one would expect a close relationship between the severity of BHR AMP and mast cell number in bronchial biopsies from allergic patients with asthma and smokers with COPD. However, we could not demonstrate such a relationship in stable patients with asthma, nor in COPD. 12,13 One explanation for this discrepancy may be that the number of mast cells was measured in the bronchial mucosa, and not in the smooth muscle area of the bronchus. After all, in vitro sensitisation with common aeroallergens increases mast cell numbers specifically within the smooth muscle area of human bronchi, in contrast to mast cells in the epithelium, lamina propia or adventitia. 14 In addition, airway smooth muscle- and mast cells may interact closely as smooth muscle cells secrete stem cell factor which activates mast cells and prolong their survival. 15 Moreover, mast cells secrete tryptase which may stimulate smooth muscles to produce TGF-b1. 16,17 This chemokine and also RANTES 18 have chemotactic activity to mast cells. Therefore, we set out to investigate whether the numbers of smooth muscle mast cells are higher in patients with asthma and COPD than in their respective non-hyperresponsive controls and if these numbers are related to the severity of BHR AMP. Materials and methods Subjects Bronchial biopsies were obtained from two previously published studies. 12,13 Subjects participating in these 2 studies were recruited from the pulmonary outpatient clinic of the University Medical Center Groningen and by advertisements in local newspapers. All subjects gave written informed consent. The medical ethics committee of the University Medical Center Groningen approved this investigation. Asthmatic subjects aged between 18 and 45 years were selected based on a history consistent with asthma: a positive history of atopy, i.e. positive intracutaneous tests against house dust mite or two other common aero-allergens (ALK, Groningen, The Netherlands), FEV l and460% predicted, PC 20 methacholinebromide p9.8 mg/ml and PC 20 AMP p80 mg/ml. Age matched healthy volunteers were selected on: no history of lung disease, FEV l and485% predicted, no atopy and no airways responsiveness to methacholine or AMP. COPD subjects aged between 45 and 75 years were selected based on criteria of the American Thoracic Society (ATS); a negative history of atopy, negative skin test to 18 common aero-allergens (ALK, Groningen, The Netherlands), i.e. negative specific serum IgE for 11 common aeroallergens (phadiatop s ). Healthy volunteers did not have a history of pulmonary disease, had a normal lung function, and were matched for age and packyears smoking. Any subject who smoked during the past year, suffered from a respiratory infection during the past 4 weeks, or was treated with oral or inhaled corticosteroids or antibiotics during the past 4 weeks was excluded. Lung function measurements Forced expiratory volume in one second (FEV 1 ) was performed according to the standardized guidelines of the European Respiratory Society. 19 Reversibility was tested 30 min after inhalation with 400 mg salbutamol. Subjects were not allowed to use short-acting bronchodilators within 12 h, or long-acting bronchodilators within 24 h. Bronchial provocation test to AMP Provocation tests were performed using a 2 min tidal breathing method. 20 After an initial nebulized saline challenge, subjects inhaled doubling concentrations AMP, ranging from 0.04 to 80 (asthma) or 320 mg/ml (COPD) (Sigma, St Louis, USA) till FEV 1 declined 20% compared to the baseline value. The arbitrary cut-off point for healthy subjects was set at 80 mg/ml AMP (asthma controls) and 320 mg/ml AMP (COPD controls). Bronchoscopy and processing of the biopsies Bronchoscopy was performed using an Olympus B1 IT10 flexible fiberoptic bronchoscope (Olympus Optical, Tokyo, Japan), according to the guidelines of the ATS. 21 Biopsies were taken from the subcarinae of the left or right lower lobe using a fenestrated forceps (FB-21C, Olympus, Tokyo, Japan). At least five biopsies per patient were collected. Biopsies were mounted in Tissue Tek s (optimal cutting temperature medium) embedding compound and snap-frozen by immersing in isopentane ( 80 1C). Every biopsy was stained with haematoxylin and eosin and qualitatively examined for the amount of smooth muscle present. Sections without smooth muscle were excluded. Frozen sections of 4 mm thickness were double immuno-stained with anti-mast cell tryptase (AA1 from DAKO, ITK, Denmark) and anti-desmin antibodies (anti-desmin from DAKO, Glostrup, Denmark, Fig. 1). Anti-mast cell antibodies were labelled with alkaline phosphatase (resulting in blue colour precipitate), and the anti-desmin antibodies with peroxidase/aec (red colour precipitate). The observer
3 884 J.J.W. Liesker et al. was blinded for subject characteristics by coding of all sections. Counting was carried out using a light microscope at a magnification of 200. Tryptase positive cells were counted in 2 random, but representative sections of one biopsy per patient with at least an 80 mm interval. Counting was started at those locations that met best the abovementioned criteria. The area of smooth muscle was determined by grid counting using an eyepiece graticule (crosspoints each 100 mm at 100 ). In this way, we evaluated per subject a mean (SD) area of 0.59 (0.40) mm 2. Mast cell number was expressed as the number of tryptase positive cells per area smooth muscle. Data analysis All analyses were performed with the SPSS 10 software package (SPSS Inc., Chicago, IL). Values of Po0:05 were considered statistically significant. The Student s t-test was used to compare clinical variables between groups, on condition of a normal distribution. The Mann Whitney U test was used to compare mast cell density between groups. Correlations between mast cell density and clinical variables were made using Spearman s rank correlation tests. Results Clinical characteristics Twenty-two patients with asthma, 18 patients with COPD, and 2 control groups of 9 healthy subjects participated in this study (Table 1). The 37 male and 21 female subjects were equally distributed between the four groups (P ¼ 0:19). Mean reversibility of the FEV 1 % predicted after 400 mg salbutamol of the asthmatic subjects was significantly larger than that of healthy controls (10.5 vs. 2.0%), whereas reversibility of patients with COPD and their healthy controls was similar (5.6 vs. 3.3, respectively). Geometric mean PC 20 AMP of the COPD patients was 52.4 mg/ml (range 1 to 4320) 9 individuals had a PC 20 AMP o320 mg/ml. Geometric mean PC 20 AMP of the asthmatic patients was 2.7 mg/ml (range ). None of the participants used mast cell stabilizers, H1 blockers, 5-lipoxygenase inhibitors, theophyllines, or any other agents that may have influenced mast cells. Differences in mast cell density in airway smooth muscle There were no significant differences between asthmatics, patients with COPD and their controls, or between the two healthy control groups (see Table 1). Figure 1 Photograph of a snap-frozen bronchial biopsy of a patient with asthma. The section was double immuno-stained with anti-mast cell tryptase (alkaline phosphatase, blue precipitate) and anti-desmin (peroxidase/aec, red precipitate). The area of smooth muscle was determined by gridcounting. Correlations between mast cell density and clinical variables In the group of 18 COPD patients, the correlation (rho) between mast cell density and FEV 1 % predicted, reversibility % predicted FEV 1 and PC 20 AMP is 0.42 (not significant), Table 1 Clinical characteristics and mast cell density. Asthma Controls for asthma COPD Controls for COPD Male/female 13/9 4/5 13/5 7/2 Age, years 31.3 (8.9) 32.3 (9.3) 62.4 (8.0) 58.7 (8.2) Pack years (0-69) 25 (10-55) Current smoking Atopy + FEV 1, % predicted 89.2 (15.8) 106 (13.9) 58.1 (13.7) 105 (11.1) Reversibility, % predicted FEV (9.9) 2.0 (1.9) 5.6 (2.5) 3.3 (3.2) PC 20 AMP, mg/ml 2.7 ( ) (1 4320) 4320 Tryptase+ cell number/mm (13 222) 127 (30 262) 122 (19 423) 130 (33 298) Baseline characteristics presented as mean (SD). PC 20 AMP presented as geometric mean (range). Tryptase+ cell number/mm 2 presented as median (range). Po0.05 vs. COPD.
4 Mast cells in airway smooth muscle 885 Figure 2 Significant correlation between the density of tryptase positive cells (mast cells) in the smooth muscle area (per mm 2 ) of bronchial biopsies and the degree of reversibility of FEV 1 % predicted in 18 subjects with stable COPD (Po0:05) (see Fig. 2), and 0.35 (not significant), respectively. In the group of 22 asthmatic patients, the correlation (rho) between mast cell density and FEV 1 % predicted, reversibility % predicted FEV 1, and PC 20 AMP is 0.17, 0.24, and 0.28, respectively (all not significant). Subgroup analyses Retrospectively we analysed the subgroup (n ¼ 9) of AMP positive COPD patients. No significant differences between COPD and their healthy controls were found regarding mast cell density in airway smooth muscle. Also, no significant correlation was found between mast cell density and PC 20 AMP. Discussion Increased bronchial hyperresponsiveness to AMP can be demonstrated in all asthmatics and many patients with COPD. Increased BHR AMP may be caused by a release of mast cell histamine, which induces smooth muscle contraction. Therefore, it was expected to find a close relationship between mast cell density in airway wall biopsies in the epithelial and subepitelial layer and PC 20 AMP. In former studies no such relationship was found, neither in patients with asthma nor in patients with COPD. Therefore, we speculated that we might have to look more specifically to mast cells in the smooth muscle area of bronchial biopsies. Nevertheless, in the present study mast cell density in smooth muscle area was not increased in asthma and COPD compared to age matched controls, and mast cell density did not correlate with BHR AMP. Interestingly, we demonstrated a negative correlation between mast cell density and reversibility of airway obstruction to salbutamol in COPD patients, despite the low level of reversibility present. We do not have a good explanation for the latter finding. There are several explanations why mast cell numbers in airway smooth muscle are not increased in our patients with asthma or COPD, and why this is not related to severity of bronchial hyperresponsiveness to AMP. First, mast cell numbers increase upon allergen exposure 22 and smoking. 11,23 Our patients were very stable and not recently exposed to allergens or cigarette smoke. It may thus well be that the mast cells in the bronchial wall were not increased in number nor activated. Second, we took bronchial biopsies from the central, but not peripheral airways. It is possible that peripheral mast cell activation is more important than central mast cell activation with respect to increased hyperresponsiveness to AMP, since it has been shown that mast cell mediators (histamine, prostagandin D2, tryptase) are increased in (peripherally collected) BAL fluid after challenge with AMP. 5 In line with this Carroll et al. showed in patients with fatal and non-fatal asthma that the density of mast cells in the complete bronchial wall, but also in airway smooth muscle, is much higher in the peripheral airways than in the central airways. Moreover, a significant part of these mast cells (66 75%) was found to be degranulated. 24 Third, we took bronchial biopsies that represent only small and superficial parts of the bronchial wall. In contrast, the complete smooth muscle area of bronchial sections was examined in the study of Ammit et al. 14 who showed increased numbers of mast cells in sensitised smooth muscle. Fourth, we applied specific immunostaining techniques directed at tryptase (AA1), using the light microscope to evaluate the number of tryptase positive cells. Although less likely in our stable study subjects, it cannot completely be ruled out that mast cells may have degranulated to a certain extent; these degranulated cells may not be visualized and this could contribute to underestimation of the real number of mast cells and their activation status. 25 Finally, there is evidence that other pathways than via the A2B-receptor on mast cells, namely involving the A1- receptor, may be responsible for the AMP-induced bronchoconstriction. 26,27 Although the A1-receptor is not abundantly present in the human lung tissue in binding studies, it is associated with nerves and functional studies suggest a possible neural pathway. 28,29 Furthermore, it has been shown that activation of adenosine A1 receptors directly stimulates contraction of human bronchial smooth muscle cells by activation of Ca 2+ -channels. 30 One other study investigating the same research question had different results. 31 This study demonstrated significantly more mast cells in airway smooth muscle of asthmatics than in healthy controls. Furthermore, a positive correlation was found between mast cell numbers in smooth muscle areas and bronchial hyperresponsiveness to methacholine in asthmatics. There are some differences between their and our study. First their asthmatics were on average 10 years younger and some of their asthmatics were nonatopic. They used a (semi)automatic computerized method while we counted manually. Finally they used methacholine to stimulate airway smooth muscle; a challenge not acting via mast cells. In contrast in our study AMP was used to stimulate airway smooth muscle cells indirectly by releasing histamine from immunologically primed mast cells. Therefore, it is intriguing that they found a positive correlation between mast cell density and hyperresponsiveness, while we did not. Obviously more studies are needed using both AMP and methacholine to determine the relationship between bronchial hyperresponsiveness and mast cell infiltration in airway smooth muscle.
5 886 J.J.W. Liesker et al. This study demonstrated a weak negative correlation between airway mast cell density in the smooth muscle area and reversibility of airway obstruction in COPD patients (rho ¼ 0.47, P ¼ 0:048), which was not present in asthma. Interestingly, Grashoff and coworkers 23 demonstrated a very similar correlation between mast cell density and reversibility of airway obstruction (rho ¼ 0.42, P ¼ 0:03) in smoking and non-smoking individuals with and without COPD. They used resected lung specimens, demonstrating the above-described relationship in the non-epithelial part of the small airways. There are a few hypothetical explanations why an increased airway mast cell density may be related to a loss of airway reversibility with salbutamol. Mediators of airway inflammatory cells, including mast cells, may impair the function of b 2 -receptors. 32,33 However, one would also expect to find a relationship between increased mast cell density and increased BHR AMP, if an increased bronchomotor tone due to desensitised b 2 - receptor function plays a role. Furthermore, mediators of inflammatory cells in the airway wall may lead to a decreased distensibility, which may be an expression of airway remodelling. Indeed mast cells have been suggested to contribute importantly to the development of airway fibrosis via proteolytic activation cascades and/or the release of heparin and subsequent effects on growth factor activity, but future studies have to confirm this. 34 We conclude that mast cell numbers in airway smooth muscle in central airways do not contribute importantly to bronchial hyperresponsiveness to adenosine neither in asthma nor in ex-smokers with COPD. Acknowledgements This study was supported by a grant from the Netherlands Asthma Foundation (grant no ), Stichting Astma Bestrijding, and by a grant from AstraZeneca, Zoetermeer, The Netherlands. References 1. Oosterhoff Y, de Jong JW, Jansen MA, Koeter GH, Postma DS. Airway responsiveness to adenosine 5 0 -monophosphate in chronic obstructive pulmonary disease is determined by smoking. Am Rev Respir Dis 1993;147(3): Oosterhoff Y, Postma DS, Koeter GH. Inflammation and airways hyperresponsiveness in asthma. Res Clin Forums 1992;14: Van Schoor J, Joos GF, Pauwels RA. Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research. Eur Respir J 2000; 16(3): Phillips GD, Ng WH, Church MK, Holgate ST. The response of plasma histamine to bronchoprovocation with methacholine, adenosine 5 0 -monophosphate, and allergen in atopic nonasthmatic subjects. Am Rev Respir Dis 1990;141(1): Polosa R, Ng WH, Crimi N, et al. Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma. Am J Respir Crit Care Med 1995;151(3 Pt 1): Polosa R, Holgate ST. Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma? Thorax 1997;52(10): Aalbers R, Kauffman HF, Koeter GH, Postma DS, De Vries K, De Monchy JG. Dissimilarity in methacholine and adenosine monophosphate responsiveness 3 and 24 h after allergen challenge. Am Rev Respir Dis 1991;144(2): van den Berge M, Meijer RJ, Kerstjens HA, et al. PC(20) adenosine 5 0 -monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine. Am J Respir Crit Care Med 2001;163(7): Oosterhoff Y, Koeter GH, De Monchy JG, Postma DS. Circadian variation in airway responsiveness to methacholine, propranolol, and AMP in atopic asthmatic subjects. Am Rev Respir Dis 1993;147(3): Lamb D, Lumsden A. Intra-epithelial mast cells in human airway epithelium: evidence for smoking-induced changes in their frequency. Thorax 1982;37(5): Pesci A, Rossi GA, Bertorelli G, Aufiero A, Zanon P, Olivieri D. Mast cells in the airway lumen and bronchial mucosa of patients with chronic bronchitis. Am J Respir Crit Care Med 1994; 149(5): Ten Hacken NH, Timens W, Smith M, Drok G, Kraan J, Postma DS. Increased peak expiratory flow variation in asthma: severe persistent increase but not nocturnal worsening of airway inflammation. Eur Respir J 1998;12(3): Rutgers SR, Timens W, Tzanakis N, Kauffman HF, van der Mark TW, Koeter GH, Postma DS. Airway inflammation and hyperresponsiveness to adenosine 5 0 -monophosphate in chronic obstructive pulmonary disease. Clinical and experimental allergy 2000;30(5): Ammit AJ, Bekir SS, Johnson PR, Hughes JM, Armour CL, Black JL. Mast cell numbers are increased in the smooth muscle of human sensitized isolated bronchi. Am J Respir Crit Care Med 1997;155(3): Kassel O, Schmidlin F, Duvernelle C, Gasser B, Massard G, Frossard N. Human bronchial smooth muscle cells in culture produce stem cell factor. Eur Respir J 1999;13(5): Olsson N, Piek E, ten Dijke P, Nilsson G. Human mast cell migration in response to members of the transforming growth factor-beta family. J Leukoc Biol 2000;67(3): Berger P, Girodet PO, Begueret H, et al. Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis. FASEB J 2003;17(14): Mattoli S, Ackerman V, Vittori E, Marini M. Mast cell chemotactic activity of RANTES. Biochem Biophys Res Commun 1995;209(1): Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16: Juniper EF, Frith PA, Dunnett C, Cockcroft DW, Hargreave FE. Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax 1978;33(6): Summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 1985;132(1): Gauvreau GM, Lee JM, Watson RM, Irani AM, Schwartz LB, O Byrne PM. Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics. Am J Respir Crit Care Med 2000;161(5): Grashoff WF, Sont JK, Sterk PJ, et al. Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages. Am J Pathol 1997;151(6): Carroll NG, Mutavdzic S, James AL. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J 2002;19(5): Djukanovic R, Wilson JW, Britten KM, et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic
6 Mast cells in airway smooth muscle 887 atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990;142(4): Polosa R. Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease. Eur Respir J 2002;20(2): Spicuzza L, Di Maria G, Polosa R. Adenosine in the airways: implications and applications. Eur J Pharmacol 2006; 533(1 3): O Connor BJ, Chung KF, Chen-Worsdell YM, Fuller RW, Barnes PJ. Effect of inhaled furosemide and bumetanide on adenosine 5 0 -monophosphate- and sodium metabisulfite-induced bronchoconstriction in asthmatic subjects. Am Rev Respir Dis 1991; 143(6): Polosa R, Rajakulasingam K, Prosperini G, Church MK, Holgate ST. Relative potencies and time course of changes in adenosine 5 0 -monophosphate airway responsiveness with inhaled furosemide and bumetanide in asthma. J Allergy Clin Immunol 1993;92(2): Ethier MF, Madison JM. Adenosine A1 receptors mediate mobilization of calcium in human bronchial smooth muscle cells. Am J Respir Cell Mol Biol 2006;35(4): Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002;346(22): Barnes PJ. Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 1995;152(3): Amrani Y, Panettieri Jr RA. Cytokines induce airway smooth muscle cell hyperresponsiveness to contractile agonists. Thorax 1998;53(8): Shute JK. Growth factor extracellular matrix interactions in bronchial tissue in asthma. In: Howarth PH, editor. Airway remodeling. Basel: Marcel Dekker, Inc; p
Increased peak expiratory flow variation in asthma: severe persistent increase but not nocturnal worsening of airway inflammation
Eur Respir J 998; : 5655 DOI:.83/93936.98.356 Printed in UK - all rights reserved Copyright ERS Journals Ltd 998 European Respiratory Journal ISSN 93-936 Increased peak expiratory flow variation in asthma:
More informationBorg scores before and after challenge with adenosine 5'-monophosphate and methacholine in subjects with COPD and asthma
Eur Respir J 2000; 16: 486±490 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 2000 European Respiratory Journal ISSN 0903-1936 Borg scores before and after challenge with adenosine 5'-monophosphate
More informationAdenosine 5 0 -monophosphate increases levels of leukotrienes in breath condensate in asthma
Respiratory Medicine (2004) 98, 651 655 Adenosine 5 0 -monophosphate increases levels of leukotrienes in breath condensate in asthma E. Bucchioni, Z. Csoma, L. Allegra, K.F. Chung, P.J. Barnes, S.A. Kharitonov*
More informationImpact of Asthma in the U.S. per Year. Asthma Epidemiology and Pathophysiology. Risk Factors for Asthma. Childhood Asthma Costs of Asthma
American Association for Respiratory Care Asthma Educator Certification Prep Course Asthma Epidemiology and Pathophysiology Robert C. Cohn, MD, FAARC MetroHealth Medical Center Cleveland, OH Impact of
More informationInflammation in chronic obstructive pulmonary disease : its assessment and the effects of corticosteroids Boorsma, M.
UvA-DARE (Digital Academic Repository) Inflammation in chronic obstructive pulmonary disease : its assessment and the effects of corticosteroids Boorsma, M. Link to publication Citation for published version
More informationLife-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton
Life-long asthma and its relationship to COPD Stephen T Holgate School of Medicine University of Southampton Definitions COPD is a preventable and treatable disease with some significant extrapulmonary
More informationresponsiveness in asthmatic patients and smokers
63 Department of Pulmonology B Auffarth D S Postma G H Koeter Th W van der Mark Department of Allergology J G R de Monchy University Hospital, 973 EZ Groningen, The Netherlands Reprint requests to: Professor
More informationT he paramount aim of asthma management is complete
925 ASTHMA Childhood factors associated with asthma remission after 30 year follow up J M Vonk, D S Postma, H M Boezen, M H Grol, J P Schouten, G H Koëter, J Gerritsen... See end of article for authors
More informationMechanisms of action of bronchial provocation testing
Mechanisms of action of bronchial provocation testing TSANZ / ANZSRS Masterclass: April 3rd, 2016 13:00 13:30 John D. Brannan PhD Scientific Director - Dept. Respiratory & Sleep Medicine John Hunter Hospital,
More informationVariation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies
Eur Respir J 1998; 12: 811 815 DOI: 10.1183/09031936.98.12040811 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1998 European Respiratory Journal ISSN 0903-1936 Variation in the measurements
More informationDistribution and degranulation of airway mast cells in normal and asthmatic subjects
Eur Respir J 22; 19: 879 885 DOI: 1.1183/931936.2.27582 Printed in UK all rights reserved Copyright #ERS Journals Ltd 22 European Respiratory Journal ISSN 93-1936 Distribution and degranulation of airway
More informationMAST CELLS IN AIRWAY SMOOTH MUSCLE IN ASTHMA MAST-CELL INFILTRATION OF AIRWAY SMOOTH MUSCLE IN ASTHMA. Study Subjects
MAST-CELL INFILTRATION OF AIRWAY SMOOTH MUSCLE IN ASTHMA CHRISTOPHER E. BRIGHTLING, M.B., B.S., PETER BRADDING, D.M., FIONA A. SYMON, PH.D., STEPHEN T. HOLGATE, M.D., D.SC., ANDREW J. WARDLAW, PH.D., AND
More informationDÉSIRÉE F. JANSEN, JAN P. SCHOUTEN, JUDITH M. VONK, BERT RIJCKEN, WIM TIMENS, JAN KRAAN, SCOTT T. WEISS, and DIRKJE S. POSTMA
Smoking and Airway Hyperresponsiveness Especially in the Presence of Blood Eosinophilia Increase the Risk to Develop Respiratory Symptoms A 25-year Follow-up Study in the General Adult Population DÉSIRÉE
More informationImmunology of Asthma. Kenneth J. Goodrum,Ph. Ph.D. Ohio University College of Osteopathic Medicine
Immunology of Asthma Kenneth J. Goodrum,Ph Ph.D. Ohio University College of Osteopathic Medicine Outline! Consensus characteristics! Allergens:role in asthma! Immune/inflammatory basis! Genetic basis!
More informationE-1 Role of IgE and IgE receptors in allergic airway inflammation and remodeling
E-1 Role of IgE and IgE receptors in allergic airway inflammation and remodeling Ruby Pawankar, MD, Ph.D. FRCP, FAAAAI Prof. Div of Allergy, Dept of Pediatrics Nippon Medical School Tokyo, Japan pawankar.ruby@gmail.com
More informationDo current treatment protocols adequately prevent airway remodeling in children with mild intermittent asthma?
Respiratory Medicine (2006) 100, 458 462 Do current treatment protocols adequately prevent airway remodeling in children with mild intermittent asthma? Haim S. Bibi a,, David Feigenbaum a, Mariana Hessen
More informationUniversity of Groningen
University of Groningen Reticular basement membrane in asthma and COPD Liesker, Jeroen J W; ten Hacken, Nick H.T.; Zeinstra - Smith, Mieke; Rutgers, Steven R; Postma, Dirkje S; Timens, Willem Published
More informationFVC to Slow Inspiratory Vital Capacity Ratio* A Potential Marker for Small Airways Obstruction
Original Research PSYCHOLOGICAL TESTING FVC to Slow Inspiratory Vital Capacity Ratio* A Potential Marker for Small Airways Obstruction Judith Cohen, MD; Dirkje S. Postma, MD, PhD; Karin Vink-Klooster;
More informationBronchodilator Response in Patients with Persistent Allergic Asthma Could Not Predict Airway Hyperresponsiveness
ORIGINAL ARTICLE Bronchodilator Response in Patients with Persistent Allergic Asthma Could Not Predict Airway Hyperresponsiveness Bojana B. Petanjek, MD, Sanja P. Grle, MD, Dubravka Pelicarić, MD, and
More informationChronic Cough Due to Nonasthmatic Eosinophilic Bronchitis. ACCP Evidence-Based Clinical Practice Guidelines
Chronic Cough Due to Nonasthmatic Eosinophilic Bronchitis ACCP Evidence-Based Clinical Practice Guidelines Christopher E. Brightling, MBBS, PhD, FCCP Objectives: Nonasthmatic eosinophilic bronchitis is
More informationDifferential Effect of Formoterol on Adenosine Monophosphate and Histamine Reactivity in Asthma
Differential Effect of Formoterol on Adenosine Monophosphate and Histamine Reactivity in Asthma JULIA A. NIGHTINGALE, DUNCAN F. ROGERS, and PETER J. BARNES Thoracic Medicine, National Heart and Lung Institute,
More informationPeak Expiratory Flow Variability Adjusted by Forced Expiratory Volume in One Second is a Good Index for Airway Responsiveness in Asthmatics
ORIGINAL ARTICLE Peak Expiratory Flow Variability Adjusted by Forced Expiratory Volume in One Second is a Good Index for Airway Responsiveness in Asthmatics Kazuto Matsunaga, Masae Kanda, Atsushi Hayata,
More informationNON-SPECIFIC BRONCHIAL HYPERESPONSIVENESS. J. Sastre. Allergy Service
NON-SPECIFIC BRONCHIAL HYPERESPONSIVENESS J. Sastre. Allergy Service Asthma: definition Asthma is a syndrome defined on basis of three main aspects: 1- Symptoms due to variable and reversible airway obstruction
More informationCurrent Asthma Therapy: Little Need to Phenotype. Phenotypes of Severe Asthma. Cellular Phenotypes 12/7/2012
Subbasement Membrane Thickness(µm) 12/7/212 Current Asthma Therapy: Little Need to Phenotype Phenotypes of Severe Asthma Most mild and to some degree moderate asthmatics respond well to currently available
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/21235
More informationComparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD
Eur Respir J 2000; 15: 109±115 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 2000 European Respiratory Journal ISSN 0903-1936 Comparison of induced sputum with bronchial wash, bronchoalveolar
More informationClinical significance of airway inflammation in bronchcial asthma. Comparison with chronic obstructive bronchiolitis.
24 Airway inflammation in asthma Clinical significance of airway inflammation in bronchcial asthma. Comparison with chronic obstructive bronchiolitis. Yoshiro Tanizaki, Hikaru Kitani, Takashi Mifune, Fumihiro
More informationRole of bronchoprovocation tests in identifying exercise-induced bronchoconstriction in a non-athletic population: a pilot study
Original Article Role of bronchoprovocation tests in identifying exercise-induced bronchoconstriction in a non-athletic population: a pilot study Jessica H. Y. Tan 1 *, Wui Mei Chew 1 *, Therese S. Lapperre
More informationAirway Inflammation in Asthma Chih-Yung Chiu 1,2, Kin-Sun Wong 2 1 Department of Pediatrics, Chang Gung Memorial Hospital, Keelung, Taiwan.
REVIEW ARTICLE Chih-Yung Chiu 1,2, Kin-Sun Wong 2 1 Department of Pediatrics, Chang Gung Memorial Hospital, Keelung, Taiwan. 2 Division of Pediatric Pulmonology, Department of Pediatrics, Chang Gung Memorial
More informationC linicians have long regarded asthma as a heterogeneous
875 ORIGINAL ARTICLE Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids R H Green, C E Brightling,
More informationSevere exacerbations predict excess lung function decline in asthma
ERJ Express. Published on May 30, 2007 as doi: 10.1183/09031936.00165106 Severe exacerbations predict excess lung function decline in asthma TR Bai 1, JM Vonk 2, DS Postma 3, HM Boezen 2 1 James Hogg icapture
More informationInduced sputum to assess airway inflammation: a study of reproducibility
Clinical and Experimental Allergy. 1997. Volume 27. pages 1138-1144 Induced sputum to assess airway inflammation: a study of reproducibility A. SPANEVELLO, G. B. MIGLIORI. A. SHARARA*, L. BALLARDlNIt,
More informationC ough variant asthma, gastro-oesophageal reflux associated
14 ASTHMA Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma? M Fujimura, H Ogawa, Y Nishizawa, K Nishi... See end of article for authors affiliations... Correspondence
More informationSearching for Targets to Control Asthma
Searching for Targets to Control Asthma Timothy Craig Distinguished Educator Professor Medicine and Pediatrics Penn State University Hershey, PA, USA Inflammation and Remodeling in Asthma The most important
More informationIgE-mediated allergy in elderly patients with asthma
Allergology international (1997) 46: 237-241 Original Article IgE-mediated allergy in elderly patients with asthma Fumihiro Mitsunobu, Takashi Mifune, Yasuhiro Hosaki, Kouzou Ashida, Hirofumi Tsugeno,
More informationDiagnosis and Management of Fungal Allergy Monday, 9-139
Diagnosis and Management of Fungal Allergy Monday, 9-139 13-2010 Alan P. Knutsen,, MD Director, Pediatric Allergy & Immunology Director, Jeffrey Modell Diagnostic Center for Primary Immunodeficiencies
More informationValue of measuring diurnal peak flow variability in the recognition of asthma: a study in general practice
Eur Respir J ; : DOI:./.. Printed in UK - all rights reserved Copyright ERS Journals Ltd European Respiratory Journal ISSN - Value of measuring diurnal peak flow variability in the recognition of asthma:
More informationFrequency of nocturnal symptoms in asthmatic children attending a hospital out-patient clinic
Eur Respir J, 1995, 8, 2076 2080 DOI: 10.1183/09031936.95.08122076 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1995 European Respiratory Journal ISSN 0903-1936 Frequency of nocturnal
More informationBeta 2 adrenoceptor agonists and the Olympic Games in Athens
Beta 2 adrenoceptor agonists and the Olympic Games in Athens 1 Appendix A of the Olympic Movement Anti-Doping Code, the List of Prohibited Substances and Prohibited Methods dated 1 st January 2003 states
More informationChronic cough is defined as a cough persisting for. Airway Inflammation as an Assessment of Chronic Nonproductive Cough*
Airway Inflammation as an Assessment of Chronic Nonproductive Cough* Sang Yeub Lee, MD ; Jae Youn Cho, MD; Jae Jeong Shim, MD; Han Kyeom Kim, MD; Kyung Ho Kang, MD, FCCP; Se Hwa Yoo, MD; and Kwang Ho In,
More informationClinical and inflammatory determinants of bronchial hyperresponsiveness in COPD
Eur Respir J 212; : 19 115 DOI: 1.113/931936.169711 CopyrightßERS 212 Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD Maarten van den Berge*,#, Judith M. Vonk #,", Margot
More informationBronchial hyperresponsiveness in asthmatic adults A long-term correlation study
European Review for Medical and Pharmacological Sciences 2005; 9: 125-131 Bronchial hyperresponsiveness in asthmatic adults A long-term correlation study R. CARBONE, F. LUPPI *, A. MONSELISE **, G. BOTTINO
More informationDeterminants of the bronchodilation response to salbutamol on histamine-induced bronchoconstriction
Respiratory Medicine (2006) 100, 1760 1766 Determinants of the bronchodilation response to salbutamol on histamine-induced bronchoconstriction Heikki O. Koskela a,, Vesa Kiviniemi b, Minna K. Purokivi
More informationMast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis
Eur Respir J 212; 39: 1361 1367 DOI: 1.1183/931936.84411 CopyrightßERS 212 Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis Amir Soltani, Yean Pin Ewe,+, Zhen
More informationMedicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air
Medicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air through the airways. As asthma, COPD ( chronic bronchitis
More informationIncreased Leukotriene E 4 in the Exhaled Breath Condensate of Children With Mild Asthma*
CHEST Original Research Increased Leukotriene E 4 in the Exhaled Breath Condensate of Children With Mild Asthma* Atsushi Shibata, MD; Toshio Katsunuma, MD, PhD; Morimitsu Tomikawa, MD; Aiko Tan, MD; Keisuke
More informationPotent and Selective CRTh2 Antagonists are Efficacious in Models of Asthma, Allergic Rhinitis and Atopic Dermatitis
Potent and Selective CRTh2 Antagonists are Efficacious in Models of Asthma, Allergic Rhinitis and Atopic Dermatitis Laura L. Carter, Yoshi Shiraishi, Yooseob Shin, Laurence Burgess, Christine Eberhardt,
More informationCOPD and Asthma: Similarities and differences Prof. Peter Barnes
and Asthma: Similarities and Differences and Asthma: 1 Imperial College Peter Barnes FRS, FMedSci, National Heart & Lung Institute Imperial College, London, UK p.j.barnes@imperial.ac.uk Royal Brompton
More informationPropranolol inhalation challenge in relation to
Propranolol inhalation challenge in relation to histamine response in children with asthma Thorax 1988;43:451-455 J GERRITSEN, G H KOTER, L T VANDERWEELE, K KNOL From the Paediatric and Internal Departments
More informationBronchial asthma is a chronic inflammatory disorder
Increased Expression of the Chemoattractant Cytokines Eotaxin, Monocyte Chemotactic Protein-4, and Interleukin-16 in Induced Sputum in Asthmatic Patients* Rame A. Taha, MD; Sophie Laberge, MD; Qutayba
More informationAllergy and Immunology Review Corner: Chapter 75 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al.
Allergy and Immunology Review Corner: Chapter 75 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al. Chapter 75: Approach to Infants and Children with Asthma
More informationExhaled Nitric Oxide: An Adjunctive Tool in the Diagnosis and Management of Asthma
Exhaled Nitric Oxide: An Adjunctive Tool in the Diagnosis and Management of Asthma Jason Debley, MD, MPH Assistant Professor, Pediatrics Division of Pulmonary Medicine University of Washington School of
More informationBRONCHIAL THERMOPLASTY
Review Article 155 BRONCHIAL THERMOPLASTY Prince James* and Richa Gupta* (Received on 4.5.2010; Accepted after revision on 5.9.2011) Summary: Even with the use of maximum pharmacological treatment, asthma
More informationEffect of oral prednisolone on the bronchoprotective effect of formoterol in patients with persistent asthma
Eur Respir J 2001; 17: 374 379 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2001 European Respiratory Journal ISSN 0903-1936 Effect of oral prednisolone on the bronchoprotective effect
More informationAirway Hyperresponsiveness to Hypertonic Saline as a Predictive Index of Exercise-Induced Bronchoconstriction
The Korean Journal of Internal Medicine: 20:284-289, 2005 Airway Hyperresponsiveness to Hypertonic Saline as a Predictive Index of Exercise-Induced Bronchoconstriction Inseon S. Choi, M.D., Se-Woong Chung,
More informationAsthma Phenotypes, Heterogeneity and Severity: The Basis of Asthma Management
Asthma Phenotypes, Heterogeneity and Severity: The Basis of Asthma Management Eugene R. Bleecker, MD Professor and Director, Center for Genomics & Personalized Medicine Research Professor, Translational
More informationNG80. Asthma: diagnosis, monitoring and chronic asthma management (NG80)
Asthma: diagnosis, monitoring and chronic asthma management (NG80) NG80 NICE has checked the use of its content in this product and the sponsor has had no influence on the content of this booklet. NICE
More informationCOPYRIGHTED MATERIAL. Definition and Pathology CHAPTER 1. John Rees
CHAPTER 1 Definition and Pathology John Rees Sherman Education Centre, Guy s Hospital, London, UK OVERVIEW Asthma is an overall descriptive term but there are a number of more or less distinct phenotypes
More informationKun Jiang 1, He-Bin Chen 1, Ying Wang 1, Jia-Hui Lin 2, Yan Hu 1, Yu-Rong Fang 1
Original Article Changes in interleukin-17 and transforming growth factor beta 1 levels in serum and bronchoalveolar lavage fluid and their clinical significance among children with asthma Kun Jiang 1,
More informationRespiratory Pharmacology
Allergy Targets of allergies Type I Histamine Leukotrienes Prostaglandins Bradykinin Hypersensitivity reactions Asthma Characterised by Triggered by Intrinsic Extrinsic (allergic) Mediators Result Early
More informationSafety, PK and PD of ARRY-502, a CRTh2 Antagonist, in Healthy Subjects with a History of Seasonal Allergies
Safety, PK and PD of ARRY502, a CRTh2 Antagonist, in Healthy Subjects with a History of Seasonal Allergies L. Burgess*, L. Anderson, C. Nugent, N. Klopfenstein, C. Eberhardt, L. Carter, C. Kass, S. RojasCaro,
More informationYoung Yoo, MD; Jinho Yu, MD; Do Kyun Kim, MD; and Young Yull Koh, MD
Original Research ASTHMA Percentage Fall in FVC at the Provocative Concentration of Methacholine Causing a 20% Fall in FEV 1 in Symptomatic Asthma and Clinical Remission During Adolescence* Young Yoo,
More informationOn completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children
7 Asthma Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists
More informationOutline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?
Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications? Fernando Holguin MD MPH Director, Asthma Clinical & Research Program Center for lungs and Breathing University of Colorado
More informationOptimal Assessment of Asthma Control in Clinical Practice: Is there a role for biomarkers?
Disclosures: Optimal Assessment of Asthma Control in Clinical Practice: Is there a role for biomarkers? Stanley Fineman, MD Past-President, American College of Allergy, Asthma & Immunology Adjunct Associate
More informationThe case for extra fine particle ICS:! to cover the entire lung!
The case for extra fine particle ICS: to cover the entire lung Richard J. Martin, M.D. Chairman Department of Medicine National Jewish Health The Edelstein Chair in Pulmonary Medicine Professor of Medicine
More informationHCT Medical Policy. Bronchial Thermoplasty. Policy # HCT113 Current Effective Date: 05/24/2016. Policy Statement. Overview
HCT Medical Policy Bronchial Thermoplasty Policy # HCT113 Current Effective Date: 05/24/2016 Medical Policies are developed by HealthyCT to assist in administering plan benefits and constitute neither
More informationDefining Asthma: Clinical Criteria. Defining Asthma: Bronchial Hyperresponsiveness
Defining Asthma: Clinical Criteria Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine, 2nd ed. Murray, Nadel, eds.(saunders:philadelphia)
More informationCombined use of exhaled nitric oxide and airway hyperresponsiveness in characterizing asthma in a large population survey
Eur Respir J 2000; 15: 849±855 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 2000 European Respiratory Journal ISSN 0903-1936 Combined use of exhaled nitric oxide and airway hyperresponsiveness
More informationComparison of the Effect of Short Course of Oral Prednisone in Patients with Acute Asthma
ISPUB.COM The Internet Journal of Pulmonary Medicine Volume 7 Number 1 Comparison of the Effect of Short Course of Oral Prednisone in Patients with Acute Asthma E Razi, G Moosavi Citation E Razi, G Moosavi.
More informationNedocromil sodium in obstructive airways disease: effect on symptoms and plasma protein leakage in sputum
Eur Respir J 1997; 10: 1500 1506 DOI: 10.1183/09031936.97.10071500 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1997 European Respiratory Journal ISSN 0903-1936 Nedocromil sodium in obstructive
More informationComparison of Peak Expiratory Flow Variability Between Workers With Work- Exacerbated Asthma and Occupational Asthma*
CHEST Comparison of Peak Expiratory Flow Variability Between Workers With Work- Exacerbated Asthma and Occupational Asthma* Samah Chiry, MD; André Cartier, MD; Jean-Luc Malo, MD; Susan M. Tarlo, MD, FCCP;
More informationBronchial hyperresponsiveness is generally assessed by
Provocation With Adenosine 5 -Monophosphate Increases Sputum Eosinophils* Maarten van den Berge, MD; H.A.M. Kerstjens, PhD; D.M. de Reus; H.F. Kauffman, PhD; G.H. Koëter, PhD; and D.S. Postma, PhD (CHEST
More informationM.O. Hoekstra*, H. Hovenga**, J. Gerritsen*, H.F. Kauffman**
Eur Respir J, 1996, 9, 2231 2235 DOI: 1.1183/931936.96.9112231 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1996 European Respiratory Journal ISSN 93-1936 Eosinophils and eosinophil-derived
More informationTolerance to bronchodilating effects of salmeterol in COPD
Respiratory Medicine (2003) 97, 1014 1020 Tolerance to bronchodilating effects of salmeterol in COPD J.F. Donohue a, *, S. Menjoge b, S. Kesten b a University of North Carolina School of Medicine, 130
More informationTHE PHARMA INNOVATION - JOURNAL Clinical Characteristics of Chronic Obstructive Pulmonary Disease
Received: 09012014 Accepted: 30032014 ISSN: 2277 7695 CODEN Code: PIHNBQ ZDBNumber: 26630382 IC Journal No: 7725 Vol. 3 No. 2. 2014 Online Available at www.thepharmajournal.com THE PHARMA INNOVATION JOURNAL
More informationA comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma
Eur Respir J 1999; 1: 591±596 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 1999 European Respiratory Journal ISSN 93-1936 A comparison of global questions versus health status questionnaires
More informationDr Rodney Itaki Lecturer Division of Pathology Anatomical Pathology Discipline
Pathology of Asthma Dr Rodney Itaki Lecturer Division of Pathology Anatomical Pathology Discipline Bronchial Asthma Definition: chronic, relapsing inflammatory lung disorder characterised by reversible
More informationClinical Study Principal Components Analysis of Atopy-Related Traits in a Random Sample of Children
International Scholarly Research Network ISRN Allergy Volume 2011, Article ID 170989, 4 pages doi:10.5402/2011/170989 Clinical Study Principal Components Analysis of Atopy-Related Traits in a Random Sample
More informationAirway calibre as a confounder in interpreting
702 Medical Department TTA 7511, State University Hospital, Copenhagen, Denmark A Dirksen F Madsen T Engel L Frolund J H Heing H Mosbech Reprint requests to: Dr A Dirksen, Department of Pulmonary Medicine
More informationSoluble ADAM33 initiates airway remodeling to promote susceptibility for. Elizabeth R. Davies, Joanne F.C. Kelly, Peter H. Howarth, David I Wilson,
Revised Suppl. Data: Soluble ADAM33 1 Soluble ADAM33 initiates airway remodeling to promote susceptibility for allergic asthma in early life Elizabeth R. Davies, Joanne F.C. Kelly, Peter H. Howarth, David
More informationLeukotriene C 4 synthase polymorphisms and responsiveness to leukotriene antagonists in asthma
Blackwell Science, LtdOxford, UKBCPBritish Journal of Clinical Pharmacology0306-5251Blackwell Publishing 2003? 2003564422426Original ArticleLeukotriene C4 synthasej. J. Lima et al. Leukotriene C 4 synthase
More informationTime course of action of two inhaled corticosteroids, fluticasone propionate and budesonide
ASTHMA Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide K Phillips, J Oborne, S Lewis, T W Harrison, A E Tattersfield... See end of article for authors affiliations...
More informationAssessment of a rapid liquid based cytology method for measuring sputum cell counts
Assessment of a rapid liquid based cytology method for measuring sputum cell counts Martin MJ, Lee H, Meakin G, Green A, Simms RL, Reynolds C, Winters S*, Shaw DE, Soomro I*, Harrison TW The Asthma Centre
More informationValidity of Spirometry for Diagnosis of Cough Variant Asthma
http:// ijp.mums.ac.ir Original Article (Pages: 6431-6438) Validity of Spirometry for Diagnosis of Cough Variant Asthma Iman Vafaei 1, *Nemat Bilan 2,3, Masoumeh Ghasempour 41 1 Resident of Pediatrics,
More informationIncreased Releasability of Skin Mast Cells after Exercise in Patients with Exercise-induced Asthma
J Korean Med Sci 4; 19: 724-8 ISSN 11-8934 Copyright The Korean Academy of Medical Sciences Increased Releasability of Skin Mast Cells after Exercise in Patients with Exercise-induced Asthma The role of
More informationStarting with a Higher Dose of Inhaled Corticosteroids in Primary Care Asthma Treatment
Starting with a Higher Dose of Inhaled Corticosteroids in Primary Care Asthma Treatment THYS van der MOLEN, BETTY MEYBOOM-DE JONG, HELMA H. MULDER, and DIRKJE S. POSTMA Department of General Practice,
More informationUvA-DARE (Digital Academic Repository)
UvA-DARE (Digital Academic Repository) Peak flow variation in childhood asthma: relationship to symptoms, atopy, aiways obstruction and hyperresponsiveness Brand, P.L.P.; Duiverman, E.J.; Postma, D.S.;
More informationDefining Asthma: Clinical Criteria. Defining Asthma: Bronchial Hyperresponsiveness
Defining Asthma: Clinical Criteria Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine, 2nd ed. Murray, Nadel, eds.(saunders:philadelphia)
More informationDefining Asthma: Bronchial Hyperresponsiveness. Defining Asthma: Clinical Criteria. Impaired Ventilation in Asthma. Dynamic Imaging of Asthma
Defining Asthma: Clinical Criteria Defining Asthma: Bronchial Hyperresponsiveness Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine,
More informationCharacterisation of patients with frequent exacerbation of asthma
Respiratory Medicine (2006) 100, 273 278 Characterisation of patients with frequent exacerbation of asthma Takeharu Koga, Yuichi Oshita, Tomoko Kamimura, Hideyuki Koga, Hisamichi Aizawa First Department
More informationAsthma. Rachel Miller, MD, FAAAAI Director Allergy and Immunology New York Presbyterian Hospital. Figure 1 Asthma Prevalence,
Asthma Rachel Miller, MD, FAAAAI Director Allergy and Immunology New York Presbyterian Hospital Figure 1 Asthma Prevalence, 1980-2000 * Gap between 1995-1996 and 1997 indicates a break in trend due to
More informationRESPIRATORY BLOCK. Bronchial Asthma. Dr. Maha Arafah Department of Pathology KSU
RESPIRATORY BLOCK Bronchial Asthma Dr. Maha Arafah Department of Pathology KSU marafah@ksu.edu.sa Jan 2018 Objectives Define asthma (BA) Know the two types of asthma 1. Extrinsic or atopic allergic 2.
More informationDual-Controller Asthma Therapy: Rationale and Clinical Benefits
B/1 Dual-Controller Asthma Therapy: Rationale and Clinical Benefits MODULE B The 1997 National Heart, Lung, and Blood Institute (NHLBI) Expert Panel guidelines on asthma management recommend a 4-step approach
More informationThe effect of caffeinated coffee on airway response to methacholine and exhaled nitric oxide
Respiratory Medicine (2011) xx, 1e5 + MODEL available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed The effect of caffeinated coffee on airway response to methacholine and exhaled
More informationEffect of Bronchoconstriction on Airway Remodeling in Asthma
T h e n e w e ngl a nd j o u r na l o f m e dic i n e original article Effect of Bronchoconstriction on Airway Remodeling in Asthma Christopher L. Grainge, Ph.D., Laurie C.K. Lau, Ph.D., Jonathon A. Ward,
More informationLecture Notes. Chapter 3: Asthma
Lecture Notes Chapter 3: Asthma Objectives Define asthma and status asthmaticus List the potential causes of asthma attacks Describe the effect of asthma attacks on lung function List the clinical features
More informationRespiratory pathophysiologic responses Inflammation of small airways in asthma
Respiratory pathophysiologic responses Inflammation of small airways in asthma Qutayba Hamid, MD, PhD, a Yunling Song, MD, a Thomas C. Kotsimbos, MD, a Eleanor Minshall, PhD," Tony R. Bai, MD, b Richard
More informationKEYWORDS: Chronic obstructive pulmonary disease, inflammation, smoking, smoking cessation
Eur Respir J 2007; 30: 467 471 DOI: 10.1183/09031936.00013006 CopyrightßERS Journals Ltd 2007 Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis E. Gamble*,#, D.C.
More informationGrass pollen immunotherapy induces Foxp3 expressing CD4 + CD25 + cells. in the nasal mucosa. Suzana Radulovic MD, Mikila R Jacobson PhD,
Radulovic 1 1 2 3 Grass pollen immunotherapy induces Foxp3 expressing CD4 + CD25 + cells in the nasal mucosa 4 5 6 7 Suzana Radulovic MD, Mikila R Jacobson PhD, Stephen R Durham MD, Kayhan T Nouri-Aria
More information